⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of HansBiomed and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
HansBiomed
↗Seoul, South Korea
HansBiomed is a global biotechnology and medical device company based in South Korea, specializing in tissue engineering, biologics, and aesthetic medical devices. The company is recognized for establishing the first tissue bank in South Korea and holds multiple first-in-class products, including artificial breast implants, lifting sutures, and human tissue grafts.
With a strong focus on R&D, HansBiomed operates multiple world-class research centers and exports its products to over 100 countries. Its business portfolio spans across aesthetic medicine, bone graft materials, and acellular dermal matrices, aiming to improve quality of life through innovative biotechnology.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Medical Devices & Tissue Engineering
SIZE & FINANCIALS
Employees:201-500
Ownership:public
Status:operating
STOCK
Exchange:KOSDAQ
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Tissue engineering, Medical devices
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:HansCare, Hans Pharma, ATEMs, Mint Medical
COMPETITION
Position:Leader
LEADERSHIP
Key Executives:
Geun Young Kim - CEO
LINKS
Website:hamsbiomed.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with HansBiomed. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.